115 related articles for article (PubMed ID: 10083109)
1. Detection of allo- and autoantibodies in kidney transplantation by flow cytometry.
Rodríguez PC; Palacio JL; Arango L; Henao JE; García LF
Transplant Proc; 1999; 31(1-2):282-4. PubMed ID: 10083109
[No Abstract] [Full Text] [Related]
2. The development of chronic renal allograft rejection may be predicted early following transplantation.
O'Malley KJ; Cook DJ; Flechner SM; McCarthy JF; Thorne NA; Boparai N; Mastroianni BA; Papajcik DA; Modlin CS; Goldfarb DA; Novick AG
Transplant Proc; 1999; 31(1-2):1352-3. PubMed ID: 10083599
[No Abstract] [Full Text] [Related]
3. Modulation of anti-HLA antibody production following renal transplantation in sensitised, immunoadsorbed patients.
Bevan DJ; Carey BS; Vaughan RW; Fallon M; Higgins RM; Hendry BM; Bewick M
Transplant Proc; 1997; 29(1-2):1448. PubMed ID: 9123375
[No Abstract] [Full Text] [Related]
4. Outcome of kidney transplants in patients known to be flow cytometry crossmatch positive.
Scornik JC; Clapp W; Patton PR; Van der Werf WJ; Hemming AW; Reed AI; Howard RJ
Transplantation; 2001 Apr; 71(8):1098-102. PubMed ID: 11374409
[TBL] [Abstract][Full Text] [Related]
5. Posttransplant antidonor antibodies and chronic rejection in renal transplantation.
Kimikawa M; Tojimbara T; Nakajima I; Fuchinoue S; Teraoka S; Toma H; Agishi T
Transplant Proc; 1999 Nov; 31(7):2872-3. PubMed ID: 10578321
[No Abstract] [Full Text] [Related]
6. Flow cytometric analysis of antidonor-specific antibodies in liver transplant.
Piazza A; Adorno D; Torlone N; Valeri M; Poggi E; Monaco PI; Pisani F; Tisone G; Casciani CU
Transplant Proc; 1997 Nov; 29(7):2975-6. PubMed ID: 9365635
[No Abstract] [Full Text] [Related]
7. Clinical strategy for the management of acute humoral rejection in kidney transplantation.
Pollak R
Transplantation; 1999 Aug; 68(4):592-3. PubMed ID: 10480425
[No Abstract] [Full Text] [Related]
8. Sensitization to HLA antigens occurs in 95% of primary renal transplant rejections.
Harmer AW; Koffman CG; Heads AJ; Vaughan RW
Transplant Proc; 1995 Feb; 27(1):666-7. PubMed ID: 7879137
[No Abstract] [Full Text] [Related]
9. Immunoglobulin class switch of posttransplant panel reactive antibody and the impact on kidney allograft outcome.
Sumethkul V; Mongkolsuk T; Sujirachato K; Chiewsilp P
Transplant Proc; 1998 Jun; 30(4):1167. PubMed ID: 9636471
[No Abstract] [Full Text] [Related]
10. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Beltran Catalan S; Avila Bernabeu A; Crespo Albiach J; Montoro JA; Pallardo Mateu LM
Transplant Proc; 2012 Nov; 44(9):2529-31. PubMed ID: 23146444
[TBL] [Abstract][Full Text] [Related]
11. Evolution of chronic antibody mediated-rejection: a case report.
Cornell LD; Wong W; Saidman S; Collins AB; Colvin RB
Clin Transpl; 2006; ():463-7. PubMed ID: 18365404
[No Abstract] [Full Text] [Related]
12. Donor-specific antibodies after transplantation by flow cytometry: relative change in fluorescence ratio most sensitive risk factor for graft survival.
Christiaans MH; Overhof-de Roos R; Nieman F; van Hooff JP; van den Berg-Loonen EM
Transplantation; 1998 Feb; 65(3):427-33. PubMed ID: 9484765
[TBL] [Abstract][Full Text] [Related]
13. Detection of clinically relevant antibodies pretransplant and posttransplant with PRA-STAT. The Anti-CD45 Study Group.
Neylan J; de Smet W; Stijlemans B; Brinker K; Gonwa T; Moran J; Segers A
Transplant Proc; 1997; 29(1-2):330-2. PubMed ID: 9123025
[No Abstract] [Full Text] [Related]
14. Correlation of pretransplant allosensitization with severity of rejection biopsy.
Clark J; Kerman R; Susskind B; Katz S; Van Buren C; Kahan B
Transplant Proc; 1999; 31(1-2):751-2. PubMed ID: 10083321
[No Abstract] [Full Text] [Related]
15. Immunoadsorption in acute vascular rejection after renal transplantation.
Persson NH; Bucin D; Ekberg H; Källén R; Omnell Persson M; Simanaitis M; Sterner G; Swedenborg P
Transplant Proc; 1995 Dec; 27(6):3466. PubMed ID: 8540054
[No Abstract] [Full Text] [Related]
16. Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation.
Bachelet T; Martinez C; Del Bello A; Couzi L; Kejji S; Guidicelli G; Lepreux S; Visentin J; Congy-Jolivet N; Rostaing L; Taupin JL; Kamar N; Merville P
Transplantation; 2016 Jan; 100(1):159-66. PubMed ID: 26262501
[TBL] [Abstract][Full Text] [Related]
17. Pretransplant flow cytometry crossmatch in first cadaveric kidney transplants.
Mascaretti L; Sioli V; Puglisi G; Rossini G; Trezzi D; Scarpino C; Scalamogna M; Sirchia G
Transplant Proc; 1995 Feb; 27(1):668-70. PubMed ID: 7879138
[No Abstract] [Full Text] [Related]
18. Crossmatching for renal transplantation--a 5-year review of different cytotoxic and flow cytometric methods showing importance of the IgG anti-B-lymphocyte FACS crossmatch.
Horsburgh T; Lycett A; Mistry N; Nicholson M; Underwood I; Veitch PS; Weston S
Transplant Proc; 1997; 29(1-2):1458-9. PubMed ID: 9123380
[No Abstract] [Full Text] [Related]
19. Relevance of positive crossmatches in renal transplantation.
Horsburgh T; Mistry N; Weston S; Morgan J; Donnelly PK; Veitch PS; Bell PR
Transplant Proc; 1992 Dec; 24(6):2508-9. PubMed ID: 1465848
[No Abstract] [Full Text] [Related]
20. Pretransplant and posttransplant monitoring of anti-HLA class I IgG1 antibodies by ELISA identifies patients at high risk of graft loss.
Monteiro F; Mineiro C; Rodrigues H; de Paula FJ; Kalil J
Transplant Proc; 1997; 29(1-2):1433-4. PubMed ID: 9123368
[No Abstract] [Full Text] [Related]
[Next] [New Search]
